Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00810251 · ClinicalTrials.gov registry record
MatrixRIB Implants for Surgical Stabilization of Flail Chest Injuries: A Registry
A clinical trial of Flail Chest, sponsored by Legacy Biomechanics Laboratory.
- Completed
- Registry status
- 20
- Enrollment target
- 1
- Study location
NCT00810251: Completed study of Flail Chest, sponsored by Legacy Biomechanics Laboratory.
NCT00810251 is a study of Flail Chest that has completed, run by Legacy Biomechanics Laboratory. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00810251, a study of Flail Chest, has completed, sponsored by Legacy Biomechanics Laboratory.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this observational study is to document the treatment of serial rib fractures with MatrixRIB implants in a registry.
Conditions Studied
Interventions
- DEVICE MatrixRIB (FDA Approval # K081623)
Study Locations (1)
Oregon
- Legacy Emanuel Hospital - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2008-12 |
| Est. Completion | 2011-05 |
What the finished NCT00810251 record still lists
NCT00810251 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 1 condition, with Flail Chest appearing as the primary indexed condition, and to 1 intervention - of which MatrixRIB (FDA Approval # K081623) is the first listed.
NCT00810251 reports a single indexed study location in Oregon.
Frequently Asked Questions
What is clinical trial NCT00810251 about?
NCT00810251 is a clinical study titled "MatrixRIB Implants for Surgical Stabilization of Flail Chest Injuries: A Registry". The purpose of this observational study is to document the treatment of serial rib fractures with MatrixRIB implants in a registry.
What is the current status of trial NCT00810251?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2008-12. Estimated completion is 2011-05.
What conditions does trial NCT00810251 study?
This clinical trial studies the following conditions: Flail Chest.
What interventions are being tested in trial NCT00810251?
The interventions under investigation include: MatrixRIB (FDA Approval # K081623) (DEVICE).
Who is sponsoring clinical trial NCT00810251?
This trial is sponsored by Legacy Biomechanics Laboratory, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00810251 being conducted?
This trial has 1 study location across Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia